Thynk Health
Thynk Health offers a comprehensive cancer screening platform, specializing in lung cancer screening and incidental findings management. Their sophisticated software solution leverages artificial intelligence and deep learning to automate manual processes such as data abstraction, data entry, patient communication, and ACR Lung Cancer Screening Registry submissions. This automation allows healthcare professionals to focus on patient care and outcomes rather than data management. Key products include the Enterprise Incidental Findings Tracker and the LDCT Module. The company differentiates itself through its accurate, automated, and configurable platform, which aims to improve early cancer detection, save lives, and mitigate risks for healthcare systems. They are based in Lexington, Kentucky and are committed to developing secure, USA-based solutions.
Thynk Health
Thynk Health offers a comprehensive cancer screening platform, specializing in lung cancer screening and incidental findings management. Their sophisticated software solution leverages artificial intelligence and deep learning to automate manual processes such as data abstraction, data entry, patient communication, and ACR Lung Cancer Screening Registry submissions. This automation allows healthcare professionals to focus on patient care and outcomes rather than data management. Key products include the Enterprise Incidental Findings Tracker and the LDCT Module. The company differentiates itself through its accurate, automated, and configurable platform, which aims to improve early cancer detection, save lives, and mitigate risks for healthcare systems. They are based in Lexington, Kentucky and are committed to developing secure, USA-based solutions.
TL;DR
Product: AI-powered cancer screening and incidental findings management platform (LDCT module, Enterprise Incidental Findings Tracker)
Focus: Lung cancer screening automation and registry submissions
Headquarters: Lexington, Kentucky
Size: Approximately 11–50 employees
Funding: Seed round reported on 2021-11-22
Company Overview
Problem Domain
Cancer screening workflow automation and incidental findings management for radiology and population health programs.
Industry
Healthcare software / SaaS
Funding Track Record
Seed round reported on Nov 22, 2021; company press release references a capital raise that included the Kentucky Bluegrass Angels
Investor Signal
“Included investment from Kentucky Bluegrass Angels as part of a group of private investors”